The Mumbai bench of the National Company Law Tribunal (NCLT) on Wednesday admitted Cian Healthcare under insolvency following an application filed by one of its operational creditors over unpaid dues worth ₹1.14 crore...
Sigma’s $5.9 bln merger with Australia’s Chemist Warehouse raises regulatory concerns
Australia’s competition regulator on Thursday flagged major concerns with Sigma Healthcare’s proposed merger with retailer Chemist Warehouse Group to form a A$8.8 billion ($5.9 billion) company. The...
Kotak Alt funds Matrix founder’s buyout of Viatris API business
Kotak Alternate Asset Managers said it has invested Rs 1,445 crore in Matrix Laboratories founder Nimmagadda Prasad’s acquisition of the active pharmaceutical ingredient (API) business of Viatris. Kotak Alt made...
CX Partners buys controlling stake in fertility centre Sabine
Private equity firm CX Partners said it has picked up a controlling stake in Sabine Hospital and Research Centre, a Kerala-based fertility services, mother and child care provider, for $50 million, or about Rs 420 crore...
Mankind Pharma in race with PEs to buy BSV Group at possible valuation of Rs 13,000 crore
A consortium of Warburg Pincus and ChrysCapital will compete with TPG, Blackstone and EQT, as well as Mankind Pharma, to acquire BSV Group, formerly Bharat Serum & Vaccines Ltd, valuing it at Rs 12,000-13,000 crore...
Brazil’s Dasa, Amil in advanced talks to combine hospital businesses
Brazil’s Diagnosticos da America (Dasa) and health insurance operator Amil are in advanced talks to combine their hospital businesses, Dasa said in a securities filing on Monday. Under the current negotiations...
Mankind Pharma in race with PEs to buy BSV Group at possible valuation of Rs 13,000 crore
A consortium of Warburg Pincus and ChrysCapital will compete with TPG, Blackstone and EQT, as well as Mankind Pharma, to acquire BSV Group, formerly Bharat Serum & Vaccines Ltd, valuing it at Rs 12,000-13,000 crore...
FTC loses bid to block $320 million hospital merger in North Carolina
A U.S. judge in North Carolina has denied the U.S. Federal Trade Commission’s request to block Novant Health’s $320 million acquisition of two hospitals in the state, a deal the agency said would lead to higher prices...
Merck to buy eye-focused drug developer EyeBio for as much as $3 bln
Merck on Wednesday agreed to buy privately held biotech EyeBio for as much as $3 billion, as it looks to diversify its portfolio of experimental drugs with treatments for eye diseases. The drugmaker agreed to pay $1.3...
Merck nears $1.3 bln cash deal for eye-drug company EyeBio, WSJ reports
Merck & Co is nearing a $1.3 billion cash deal to buy ophthalmology biotechnology company Eyebiotech in an agreement that could see an additional $1.7 billion in milestone payments, the Wall Street Journal reported...
KKR invests in Healthcare Revenue Solutions provider Infinx
Global PE fund KKR has announced its acquisition of a significant minority stake in Infinx Services, the leading healthcare revenue cycle solutions provider. Through this investment, KKR will leverage its extensive...
KKR in talks to buy into healthcare BPO company Infinx
KKR is looking to acquire a minority stake in the Tandon Group-owned healthcare BPO Infinx Healthcare. The global private equity major is likely to invest about $150 million, or Rs 1,250 crore, to acquire about 26%...
